TY  - JOUR
AU  - Piñol-Jurado, Patricia
AU  - Suárez-Calvet, Xavier
AU  - Fernández-Simón, Esther
AU  - Gallardo, Eduard
AU  - de la Oliva, Natalia
AU  - Martínez-Muriana, Anna
AU  - Gómez-Gálvez, Pedro
AU  - Escudero, Luis M
AU  - Pérez-Peiró, María
AU  - Wollin, Lutz
AU  - de Luna, Noemi
AU  - Navarro, Xavier
AU  - Illa, Isabel
AU  - Díaz-Manera, Jordi
PY  - 2018
DO  - 10.1038/s41419-018-0792-6
UR  - http://hdl.handle.net/10668/12700
T2  - Cell death & disease
AB  - Duchenne muscle dystrophy (DMD) is a genetic disorder characterized by progressive skeletal muscle weakness. Dystrophin deficiency induces instability of the sarcolemma during muscle contraction that leads to muscle necrosis and replacement of muscle...
LA  - en
KW  - Action Potentials
KW  - Animals
KW  - Collagen Type I
KW  - Collagen Type I, alpha 1 Chain
KW  - Collagen Type III
KW  - Disease Models, Animal
KW  - Dystrophin
KW  - Fibrosis
KW  - Indoles
KW  - Male
KW  - Mice
KW  - Muscle Contraction
KW  - Muscle Weakness
KW  - Muscle, Skeletal
KW  - Muscular Dystrophy, Duchenne
KW  - Platelet-Derived Growth Factor
KW  - Transforming Growth Factor beta1
TI  - Nintedanib decreases muscle fibrosis and improves muscle function in a murine model of dystrophinopathy.
TY  - research article
VL  - 9
ER  -